EP3102212
Kólesterýl-Ester ferjuprótín-hemill (CETPI) og lyfjafræðilegar efnasamsetningar sem innihalda nefndan hemil til að nota í meðferð við eða til að koma í veg fyrir hjarta- og æðasjúkdóma
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
5.2.2014EP published:
7.11.2018EP application number:
14705225.2
EP translation filed:
17.1.2019Grant published:
15.3.2019EPO information:
European Patent Register
Max expiry date:
4.2.2034Expiry date:
4.2.2027Next due date:
28.2.2027
Title:
CHOLESTERYL ESTER TRANSFER PROTEIN (CETP) INHIBITOR AND PHARMACEUTICAL COMPOSITIONS COMPRISING SAID INHIBITOR FOR USE IN THE TREATMENT OR PREVENTION OF CARDIOVASCULAR DISEASES
Timeline
Today
5.2.2014EP application
7.11.2018EP Publication
17.1.2019Translation submitted
15.3.2019Registration published
4.2.2027Expires
Owner
Name:
NewAmsterdam Pharma B.V.Address:
Gooimeer 2-35, 1411 DC, Naarden, NL
Inventor
Name:
FORD, JohnAddress:
Cambridgeshire PE28 9BJ, GB
Name:
ROUND, PatrickAddress:
NewmarketSuffolk CB8 7PA, GB
Name:
KASTELEIN, JohnAddress:
NL-1076 DZ Amsterdam, NL
Name:
KAWAGUCHI, AtsuhiroAddress:
Osaka-shiOsaka, JP
Name:
TOMIYASU, KoichiAddress:
Osaka-shiOsaka, JP
Name:
OKA, KozoAddress:
Osaka-shiOsaka, JP
Agent
Name:
Tego ehf.Address:
Pósthólf 8129, 128, Reykjavík,
Classification
Categories:
A61K 31/506, A61P 3/06, A61P 9/00
Annual fees
Number
Paid
Expires
Payer
Number: 6
Paid: 24.1.2019
Expires: 4.2.2020
Payer: Árnason Faktor
Number: 7
Paid: 14.1.2020
Expires: 4.2.2021
Payer: Árnason Faktor ehf.
Number: 8
Paid: 28.2.2021
Expires: 4.2.2022
Payer: Árnason Faktor ehf.
Number: 9
Paid: 24.2.2022
Expires: 4.2.2023
Payer: Árnason Faktor ehf.
Number: 10
Paid: 22.2.2023
Expires: 4.2.2024
Payer: Árnason Faktor ehf.
Number: 11
Paid: 29.2.2024
Expires: 4.2.2025
Payer: Árnason Faktor ehf.
Number: 12
Paid: 24.3.2025
Expires: 4.2.2026
Payer: Árnason Faktor ehf.
Number: 13
Paid: 30.1.2026
Expires: 4.2.2027
Payer: Árnason Faktor ehf.